Screening and verification of key genes for colon cancer based on GEO database

doi:10.16352/j.issn.1001-6325.2023.11.1685

Abstract

Abstract: Objective To screen the potential key genes associated with colon cancer(CC) by bioinformatics analysis based on Gene Expression Omnibus (GEO) database, and verify them through in vitro experiments to explore potential colon cancer molecular markers. Methods The human CC data sets GSE10950 and GSE74602 were obtained from GEO database. The differentially expressed genes (DEGs) in colon cancer and adjacent tissues were screened by GEO2R tool and Venn diagram software. DEGs were used to perform by Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The Protein-Protein Interaction (PPI) network of DEGs was constructed by STRING database, then the key genes were screened with Cytoscape software. GEPIA database was used to validate expression and prognostic value of key genes. Finally, the functions of key genes were further verified by cell transfection and CCK8 assays. Results 515 DEGs were obtained from two datasets, of which 223 were up-regulated and 292 were down-regulated. GO enrichment analysis showed that up-regulated DEGs were mainly involved in negative regulation of cell cycle, transcriptional control. KEGG signaling pathways analysis showed that up-regulated DEGs were mainly enriched in cell cycle signaling pathways. A total of 33 hub genes were screened through the PPI. UCLCAN analysis was implemented and 7 of 33 genes were relative to lower survival rate of CC patients. The expression levels of 7 genes by GEPIA analysis (P＜0.05).It was verified by GEPIA database that CCNB1,CCNA2,CDC20,CDKN3,DLGAP5,HMMR and NCAPG were highly expressed in colon cancer tissues. KEGG pathway enrichment and found that three critical genes (CCNB1, CDC20 and CCNA2) enriched in cell cycle pathway. The inhibition of CCNB1,CDC20 or CCNA2 significantly promoted proliferation of colon cancer cells. Conclusions A total of 7 key genes were identified to be involved in the occurrence of CC. The expression of CCNB1,CDC20 and CCNA2 is potentially related to the poor prognosis in CC, which may be potential targets of clinical treatment and prognostic markers for CC patients.

Key words: colon cancer, bioinformatics analysis, differentially expressed genes, protein-protein interaction network

CLC Number:

R735.7

YAN Wen, LI Nan, GU Tongnan, KONG Xiangzhao. Screening and verification of key genes for colon cancer based on GEO database[J]. Basic & Clinical Medicine, 2023, 43(11): 1685-1692.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.11.1685

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I11/1685

References

[1]柳子朝, 杜文静, 李莉. p53转录调控靶基因GGT6对人结肠癌的影响[J]. 基础医学与临床, 2023, 43: 953-959.
[2]Zhou J, Xiong W, Wang Y, et al. Protein function prediction based on PPI networks: network reconstruction vs edge enrichment[J]. Front Genet, 2021,12:758131. doi: 10.3389/fgene.2021.758131.
[3]Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible[J].Nucleic Acids Res, 2017, 45: 362-368.
[4]李玲玲, 李倩, 李明玉, 等. 成人与儿童急性髓系白血病患者肿瘤免疫相关的差异表达基因分析[J]. 上海交通大学学报: 医学版, 2021,41: 579-587.
[5]Le NQK, Yapp EKY, Nagasundaram N, et al. Computational identification of vesicular transport proteins from sequences using deep gated recurrent units architecture[J]. Comput Struct Biotechnol J, 2019, 17: 1245-1254.
[6]贾钧儒, 屈畅, 付静璇, 等. 基于生物信息学方法的SARS-CoV-2和MERS-CoV差异表达基因分析[J]. 军事医学, 2020, 44: 746-754.
[7]黄溢问, 吴凤, 阳联, 等. 基于生物信息学耐吉非替尼非小细胞肺癌细胞的差异表达基因分析[J]. 广西医学, 2021, 43: 714-719.
[8]贾乔迪, 李莎莎, 张红宇, 等. 基于GEO数据库的肝细胞癌差异表达基因分析[J]. 郑州大学学报: 医学版, 2021,56: 713-717.
[9]Yao RQ, Ren C, Xia ZF, et al. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles[J]. Autophagy, 2021,17:385-401. doi: 10.1080/15548627.2020.1725377.
[10]Matsuda Y, Wakai T, Kubota M, et al. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma[J]. Med Mol Morphol, 2013, 46: 185-192.
[11]Feng H, Gu ZY, Li Q, et al. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis[J]. J Ovarian Res, 2019, 12: 35. doi: 10.1186/s13048-019-0508-2.
[12]Yang WX, Pan YY, You CG. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 may be potential therapeutic targets for hepatocellular carcinoma using integrated bioinformatic analysis[J]. Biomed Res Int, 2019, 2019: 1245072. doi: 10.1155/2019/1245072.
[13]Deng JL, Xu YH, Wang G. Identification of potential crucial genes and key pathways in breast cancer using bioinformatic analysis[J]. Front Genet, 2019, 10: 695. doi: 10.3389/fgene.2019.00695.
[14]Chen J, Huang X, Tao C, et al. Artemether attenuates the progression of non-small cell lung cancer by inducing apoptosis, cell cycle arrest and promoting cellular senescence[J]. Biol Pharm Bull, 2019, 42: 1720-1725.
[15]Zhang Y, Tseng JT, Lien IC, et al. mRNAsi index: machine learning in mining lung adenocarcinoma stem cell biomarkers[J]. Genes (Basel), 2020, 11:257. doi: 10.3390/genes11030257.